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ABSTRACT
Aims To report the clinicopathological characteristics of
patients with ocular adnexal marginal zone B cell
lymphoma (MZBL) with IgG4-positive plasma cells.
Methods 114 biopsy samples of ocular adnexal MZBLs
were analysed. MZBLs with IgG4-positive plasma cells
were included when the IgG4:IgG ratio was >40%
(IgG4-related group). The serum levels of each subclass
of immunoglobulins and soluble interleukin-2 receptor in
the IgG4-related group were compared with those in 61
consecutive patients having MZBL without IgG4-positive
plasma cells (IgG4-unrelated group). They were also
compared with those in 10 patients having ocular
adnexal IgG4-related lymphoplasmacytic disorder
(IgG4-related inﬂammatory group).
Results Ten (9%) of the patients were diagnosed with
MZBL with IgG4-positive plasma cells. The IgG4-related
group had a signiﬁcantly greater degree of sclerosis and
reactive follicles in the MZBLs (p¼0.0004 and p¼0.01,
respectively). The serum levels of IgG, IgG1, IgG4, IgE
and soluble interleukin 2 receptor in the IgG4-related
group were signiﬁcantly higher than those in the
IgG4-unrelated group (p¼0.003, p¼0.009, p<0.0001,
p<0.0001 and p¼0.0007, respectively). The serum
levels did not differ signiﬁcantly from those of the
IgG4-related inﬂammatory group. The IgG4-related group
also had reactive IgG4-positive lymphoplasmacytic
inﬁltrations in the recurrent lesion and in the stomach.
Conclusions IgG4-positive plasma cells had inﬁltrated
into ocular adnexal MZBLs in 9% of cases. It is
suggested that ocular adnexal MZBLs with IgG4-positive
plasma cells have unique histological and serological
characteristics that overlap those of ocular adnexal
IgG4-related lymphoplasmacytic inﬁltrative disorder and
systemic conditions.
INTRODUCTION
Ocular adnexal marginal zone B cell lymphomas
(MZBLs) make up the majority of lymphomas
arising from the ocular adnexa. They are charac-
terised histologically by the presence of reactive
follicles in up to 64% of cases, sclerosis in up to 20%
of cases, and plasma cells in up to 35% of cases.
1
Among the inﬂammatory disorders arising from the
ocular adnexa, the IgG4-related lymphoplasmacytic
inﬁltrative disorder is characterised histologically
by inﬁltration by IgG4-positive plasma cells with
reactive lymphoid hyperplasia and sclerosing
inﬂammation.
2 Ocular adnexal MZBLs are reported
to arise in IgG4-related sclerosing dacryoadenitis,
indicating a possible link between the two condi-
tions.
3 However, clinical information about ocular
adnexal MZBLs with IgG4-positive plasma cells is
not available. In addition, any causal relationship
between ocular adnexal MZBLs with IgG4-positive
plasma cells and IgG4-related lymphoplasmacytic
inﬁltrative disorder has not been established.
Thus, the purpose of this study was to determine
the clinicopathological characteristics of ocular
adnexal MZBLs inﬁltrated by IgG4-positive plasma
cells. To accomplish this goal, we analysed patients
with ocular adnexal MZBL with IgG4-positive
plasma cells and compared the ﬁndings with those
in patients with ocular adnexal MZBLs without
IgG4-positive plasma cells and patients with ocular
adnexal IgG4-related lymphoplasmacytic inﬁltra-
tive disorder.
PATIENTS AND METHODS
Patients
The procedures used in this study conformed to the
tenets of the Declaration of Helsinki and were
approved by the Ethics Committee at Nagoya
Medical Center, Nagoya, Japan. All patients
provided signed informed consent after the proce-
dures and possible outcomes were explained.
Patients with secondary ocular adnexal
lymphomas were excluded from this study. The
medical records of 114 patients with primary ocular
adnexal MZBL who were examined between April
2001 and December 2009 were evaluated. A
complete medical history and laboratory data that
included the levels of each immunoglobulin and
soluble interleukin 2 receptor (sIL-2R) were
recorded. The criterion used to diagnose ocular
adnexal MZBL with IgG4-positive plasma cells was
an IgG4:IgG ratio >40%. Of the 114 patients, 10
had ocular adnexal MZBLs with IgG4-positive
plasma cells (IgG4-related group).
Clinical data
We recorded the age, gender, laterality, lesion loca-
tion, systemic evaluations, treatments, response to
therapy and clinical follow-up ﬁndings of the 10
patients in the IgG4-related group. The pretreat-
ment stage was determined by whole-body CT
scans of the neck, chest, abdomen and pelvis. In
addition, bone marrow biopsy and gastroscopy
were performed. The disease stage at the time of
the diagnosis was classiﬁed according to that
modiﬁed for extranodal diseases
4 and the American
Joint Committee on Cancer classiﬁcation.
5
Histopathology, immunohistochemistry and
molecular genetic analysis
Biopsy specimens from the ocular adnexal lesions
were collected from all patients. Part of the biopsy
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Original articlespecimen was embedded in parafﬁn for conventional histological
and immunohistochemical analyses, and the remainder was
immediately frozen and used for Southern blot analysis. All
biopsy specimens were examined for morphological features,
and classiﬁed according to the WHO classiﬁcation.
6 The
immunophenotype, based mainly on CD20-positive, CD5-
negative, CD10-negative, CD23-negative and cyclin D1-negative
expression (Dako, Glostrup, Denmark), and k and l (by in situ
hybridisation; Ventana Medical Systems, Oro Valley, Arizona,
USA) was also determined. The IgG-positive and IgG4-positive
plasma cells were detected by immunostaining for IgG (poly-
clonal; Dako) and IgG4 (MC011; The Binding Site Group,
Birmingham, England). To determine the number of IgG4-posi-
tive or IgG-positive cells, the areas with the highest density of
IgG4-positive cells were evaluated. In each specimen, the mean
number of IgG4-positive plasma cells was determined from three
high-power ﬁelds by using methods previously described.
3 One
high-power ﬁeld covered an area of 0.196 mm
2 (magniﬁcation
3400; Nikon microscope, Tokyo, Japan). Patients with an IgG4:
IgG plasma cell ratio >40% in a high-power ﬁeld were placed in
the group with ocular adnexal MZBLs with IgG4-positive
plasma cells.
Southern blot analysis was performed on the specimens to
detect B cell clonality, that is, to determine if immunoglobulin
heavy chain gene rearrangements had occurred. A PCR method
was performed from the formalin-ﬁxed and parafﬁn-embedded
specimens by methods previously described
7 to detect B cell
clonality when fresh frozen biopsy samples were not available.
Laboratory data
Laboratory data were determined from peripheral blood
collected from all patients. The serum levels of IgA, IgM, total
IgG, IgE and sIL-2R were analysed at the time of diagnosis and
the follow-up examinations. Subclasses of IgG (IgG1, 2, 3 and 4)
were collected from April 2007 to December 2009. Each subclass
of IgG was analysed retrospectively.
Treatments
Table 1 shows the treatments for each patient. For the initial
treatment, all patients except for patients 5 and 6 received
radiotherapy at a dose of 30 Gy. Following radiotherapy,
all patients were carefully monitored, and cyclophosphamide/
doxorubicin/vincristine/prednisone (CHOP) and/or rituximab,
along with the regimen used to treat low-grade non-Hodgkin
lymphoma, were administered. This approach was based on
the criteria of either rapid enlargement of the systemic tumour
or appearance of clinical signs and symptoms, including B
symptoms.
Statistical analyses
We compared the incidence of sclerosing and follicular lesions in
the IgG4-related and IgG4-unrelated groups using the c
2 or
Fisher’s exact tests. The laboratory results were compared
between the IgG4-related group and 61 consecutive patients in
the IgG4-unrelated group, as were those between the IgG4-
related group and 10 patients with ocular adnexal IgG4-related
lymphoplasmacytic disorder (IgG4-related inﬂammatory group),
all using the ManneWhitney test. All statistical analyses were
performed on a personal computer with the SPSS statistical
package for Windows (Version 12.0; SPSS, Chicago, Illinois,
USA). A p value <0.05 was considered to be statistically
signiﬁcant.
RESULTS
Clinical data
Among the 114 patients with ocular adnexal MZBLs, 10 (9%)
met the criterion based on the immunostaining for IgG4 and
IgG. Table 1 shows the distribution of the age, gender, laterality,
American Joint Committee on Cancer staging, Ann Arbor clin-
ical staging, initial and second treatments and outcomes for the
IgG4-related group. The ﬁndings for the two patients with
polyclonal hypergammaglobulinaemia have been reported
previously.
8
Histopathology, immunohistochemistry and molecular genetic
analysis
All 114 biopsy specimens of the ocular adnexa were diagnosed as
MZBLs based on histopathological and immunohistochemical
results. The histological study of ocular adnexal MZBLs showed
sclerosing changes in 48% (55/114) of the cases and reactive
follicles in 39% (44/114).
In the IgG4-related group (ﬁgures 1 and 2), the histological
study showed sclerosing lesions in all (10/10) and reactive
follicles in 80% (8/10). The IgG4:IgG ratio for biopsy samples of
the IgG4-related group ranged from 1.0 to 0.43, in contrast to
that of the IgG4-unrelated group (ﬁgure 3), which ranged from
0.2 to 0. All biopsy specimens showed light-chain restrictions by
in situ hybridisation and also showed immunoglobulin heavy-
chain gene rearrangement by Southern blot analysis (data not
available for patients 1 and 2).
The ocular adnexal recurrent lesion for patient 2 showed
lymphoplasmacytic proliferation with IgG4-positive plasma
Table 1 Clinical characteristics of 10 patients with marginal zone B cell lymphoma with IgG4-positive plasma cells
Patient
no.
Age (years)/
gender Laterality Clinical stage*
Initial
treatment Events during follow-up Second treatment
Outcome and follow-up
(months)
1 66/M Bilateral T2cN4M0/III Radiation Malignant transformation to
diffuse large cell type
CHOP and rituximab Died from disease (36)
2 66/M Left T2cN0M0/IE Radiation Orbital LPI; gastric LPI rituximab AOD (97)
3 67/F Left T2cN0M0/IE Radiation Gastric carcinoma and LPI,
developing TNM staging N4
Gastrectomy, CHOP
and rituximab
AOD (70)
4 75/M Left T2cN0M0/IE Radiation Developing TNM staging N4 ND Died from other cause (65)
5 64/F Left T2bN0M0/IE CP Developing TNM staging N3 ND AWD (82)
6 70/M Right T2cN4M0/III Excision None ND AWD (13)
7 61/M Left T2cN0M0/IE Radiation Developing TNM staging N4 ND AWD (73)
8 90/M Left T2cN4M0/III Radiation None ND AOD (9)
9 65/M Right T2bN0M0/IE Radiation None ND AOD (26)
10 64/M Right T2cN0M0/IE Radiation None ND AOD (26)
*American Joint Committee on Cancer staging and Ann Arbor staging.
AOD, alive without disease; AWD, alive with disease; CHOP, cyclophosphamide, doxorubicin, vincristine, prednisone; LPI, lymphoplasmacytic inﬁltrations; TNM, tumour, node, metastases.
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Original articleFigure 1 Initial and second biopsy specimens for recurrent lesions of patient 2. (A) CT images showing the tumour located in the left posterior orbit
(left) at the time of diagnosis and recurring diffusely in the left posterior orbit (right) 53 months after radiotherapy. (B) Initial biopsy specimen showing
proliferation of lymphoid cells with abundant follicles and sclerosis. H&E staining, original magniﬁcation 340. (C) Immunostaining for l (left) and k
(right) of the initial biopsy specimen shows light-chain restriction. In situ hybridisation, original magniﬁcation 340. (D) Immunostaining for IgG4 shows
IgG4-positive plasma cells. The IgG4:IgG ratio was 0.43. Immunoperoxidase staining, original magniﬁcation 3400. (E) Second biopsy samples for
recurrent lesions showing reactive lymphoplasmacytic proliferations. H&E staining, original magniﬁcation 3200. Immunostaining for IgG4 shows
IgG4-positive plasma cells in the recurrent lesions. Right, the IgG4:IgG ratio was 0.62. Immunoperoxidase staining, original magniﬁcation 3200.
(F) Immunostaining for l (left) and k (right) does not show light-chain restrictions. In situ hybridisation, original magniﬁcation 3200. Southern blot
analysis did not detect heavy-chain gene rearrangement.
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Original articleFigure 2 Histological and
immunohistochemical ﬁndings in
conjunctival marginal zone B cell
lymphoma with IgG4-positive plasma
cells from patient 6. (A) Salmon-pink
mass lesions on the left bulbar
conjunctiva. CT image shows medial
rectus muscle enlargement (insert). (B)
Histological study shows dense
lymphocytic proliferation with sclerosis
and follicles. H&E staining, original
magniﬁcation 340. (C) Immunostaining
for l (left) and k (right) shows light-
chain restriction. Southern blot analysis
shows immunoglobulin heavy-chain
gene rearrangement. In situ
hybridisation, original magniﬁcation
340. (D) Higher magniﬁcation shows
small and medium-sized lymphocytes
with plasma cells and sclerosis. H&E
staining, original magniﬁcation 3400.
(E) Another higher magniﬁcation shows
lymphoplasmacytic inﬁltrations with
abundant sclerosing lesions. H&E
staining, original magniﬁcation 3400.
(F) Immunostaining for IgG4 reveals
IgG4-positive plasma cells in the
lymphoplasmacytic lesions. The IgG4:
IgG ratio was 0.53. Immunoperoxidase
staining, original magniﬁcation 3400.
Figure 3 Findings in a 67-year-old man with bilateral conjunctival marginal zone B cell lymphoma without IgG4-positive plasma cells. (A) Salmon-pink
mass lesions proliferate on the left bulbar conjunctiva. (B) Histology (left) of the lesion shows lymphoid cells proliferating without sclerosis and
follicles. H&E staining, original magniﬁcation 3100. The specimen showed light-chain restriction by in situ hybridisation and immunoglobulin heavy-
chain gene rearrangement by Southern blot analysis. Immunostaining for IgG4 (right) does not show IgG4-positive plasma cells. Immunoperoxidase
staining, original magniﬁcation 3100.
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Original articlecells and did not show either light-chain restriction or immu-
noglobulin heavy-chain gene rearrangement (ﬁgure 1). Gastric
biopsy samples during follow-up periods from patients 2 and 3
showed reactive lymphoid proliferation with IgG4-positive
plasma cells (ﬁgure 4). Immunostaining did not show light-chain
restriction by in situ hybridisation. PCR showed immunoglob-
ulin heavy-chain gene rearrangement from the gastric sample of
patients 2 and 3.
Statistical analyses showed that biopsy samples from the
IgG4-related group were signiﬁcantly associated with sclerosing
inﬁltrations (100% vs 43%; p¼0.0004; Fisher’s exact test),
reactive follicles (80% vs 35%; p¼0.01; Fisher’s exact test)
compared with those from the IgG4-unrelated group.
Systemic evaluations
Three patients (30%) had systemic lymphadenopathy at the
time of diagnosis (ﬁgure 5) involving the chest (patients 6 and
8), axillae (patient 6), and abdomen (patient 1). In contrast,
among the IgG4-unrelated group, seven (7%) had systemic
lymphadenopathy at the time of diagnosis. The IgG4-related
group had signiﬁcant systemic lymphadenopathy at the time of
diagnosis compared with that of the IgG4-unrelated group (30%
vs 7%; p¼0.04; Fisher’s exact test). Patients 3, 4, 5 and 7 had
stage I disease but later developed systemic lymphadenopathy
that involved the chest (patients 3, 4 and 7), the axillae (patients
3 and 5), abdomen (patients 3 and 4) and pelvis (patient 4).
Treatment and outcome
Table 1 shows the results of the systemic evaluations, treatment
and outcome. Following radiotherapy, all patients achieved
complete regression in the irradiated ﬁeld. Patients 2 and 3
relapsed in the irradiation ﬁeld after 65 and 24 months, respec-
tively, and also had IgG4-positive lymphoplasmacytic prolifera-
tions in the stomach. Patient 3 additionally developed gastric
carcinoma. Patient 2 received rituximab treatment, and the
recurrent lesion regressed but then gradually relapsed again.
Patient 3receivedgastrectomy andrituximabandCHOPtherapy,
and had no evidence of the disease at the ﬁnal examination.
Figure 4 Gastric biopsy samples of patients 2 and 3. (A) Histology of patient 2 shows lymphoplasmacytic proliferations in the stomach. H&E
staining, original magniﬁcation 3100. Immunostaining did not show light-chain restriction; however, the analysis of the specimen on PCR showed
immunoglobulin heavy-chain gene rearrangement. (B) Higher magniﬁcation (left) shows lymphoplasmacytic inﬁltrations. H&E staining, original
magniﬁcation 3400. Immunostaining for IgG4 (right) shows IgG4-positive plasma cells. The IgG4:IgG ratio was 0.67. Immunoperoxidase staining,
original magniﬁcation 3400. (C) Histology of patient 3 shows lymphoplasmacytic proliferations. H&E staining, original magniﬁcation 3100.
Immunostaining did not show light-chain restriction; however, the analysis of the specimen on PCR showed immunoglobulin heavy-chain gene
rearrangement. (D) Higher magniﬁcation (left) shows lymphoplasmacytic inﬁltrations. H&E staining, original magniﬁcation 3400. Immunostaining for
IgG4 (right) showed IgG4-positive plasma cells. The IgG4:IgG ratio was 0.70. Immunoperoxidase staining, original magniﬁcation 3400.
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Original articleLaboratory data
Table 2 presents the mean serum levels of IgA, IgM, IgG1e4, IgE
and sIL-2R receptor for the 10 patients in the IgG4-related
group, the 61consecutive patients in the IgG4-unrelated group,
and the 10 patients in the IgG4-related inﬂammatory group.
The serum levels of IgG, IgG1, IgG4, IgE and sIL-2R receptor
in the IgG4-related group were signiﬁcantly higher than those
in the IgG4-unrelated group (table 2; p¼0.003, p¼0.009,
p<0.0001, p<0.0001 and p¼0.0007, respectively;
ManneWhitney test). In contrast, the serum levels of IgM were
signiﬁcantly lower than those in the IgG4-unrelated group
(p¼0.02; ManneWhitney test), although, for the two groups,
serum levels of IgM were within normal limits. Between
the IgG4-related group and the IgG4-related inﬂammatory
group, neither immunoglobulin nor sIL-2R levels differed
signiﬁcantly.
Figure 5 Fluorodeoxyglucose F-18 (FDG) positron emission tomography at the initial examination of patient 6 (A) whose ocular data are presented in
ﬁgure 3 (B). FDG positron emission tomography of patient 6 showed accumulation of FDG in the right ocular adnexa, chest and left axillae (arrowheads)
at the time of the diagnosis. Fusion images demonstrate not only swelling of several bronchomediastinal lymph nodes (arrows), but also the metabolic
activity of the lesions. In contrast, the patient in ﬁgure 3 shows none of the accumulations including in the ocular adnexa.
Table 2 Serological data of patients with ocular adnexal MZBL with or without IgG4-positive plasma cells, and patients with ocular adnexal
IgG4-related lymphoplasmacytic disorder
Serological data (normal range)
IgG4-related
group, n[10
IgG4-unrelated
group, n[61
IgG4-related inﬂammatory
group, n[10 p Value* p Valuey
IgA (110e410 mg/dl) 214 (109) 228 (103) 229 (149) 0.6 0.7
IgM (33e190 mg/dl) 102 (58) 157 (93) 78 (58) 0.02 0.09
Total IgG (870e1700 mg/dl) 2432 (1944) 1287 (406) 2732 (1749) 0.003 1.0
IgG1 (320e748 mg/dl) 858 (193) 655 (190) 1047 (418) 0.009 0.4
IgG2 (208e754 mg/dl) 607 (232) 494 (172) 836 (465) 0.2 0.4
IgG3 (7e88 mg/dl) 86 (72) 44 (35) 66 (47) 0.2 0.9
IgG4 (5e105 mg/dl) 415 (295) 48 (46) 901 (890) <0.0001 0.2
IgE (<170 IU/ml) 1581 (1717) 293 (509) 1020 (1159) <0.0001 0.2
sIL-2R (135e483 U/ml) 943 (525) 465 (392) 941 (579) 0.0007 0.9
Values are mean (standard deviation).
IgG4-related group: patients having ocular adnexal MZBL with IgG4-positive plasma cells; IgG4-related inﬂammatory group: patients with ocular adnexal IgG4-related lymphoplasmacytic
inﬁltrative disorder; IgG4-unrelated group: patients having ocular adnexal MZBL without IgG4-positive plasma cells.
*IgG4-related group versus IgG4-unrelated group.
yIgG4-related group versus IgG4-related inﬂammatory group.
MZBL, marginal zone B cell lymphoma; sIL-2R, soluble interleukin-2 receptor.
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Nine per cent of the cases of ocular adnexal MZBLs consisted of
IgG4-positive plasma cells with sclerosing and reactive follicular
lesions. Sclerosing and reactive follicles had a relatively high
incidence in our cases of ocular adnexal MZBLs. However, on the
basis of the unique systemic and serological characteristics of the
IgG4-related group, we suggest that IgG4-positive plasma cells
with sclerosing and reactive follicles are speciﬁci n ﬂammatory
lesions in ocular adnexal MZBLs.
IgG4-positive plasma cell inﬁltrations with sclerosing and
reactive follicles in the IgG4-related group were similar to those
already published for the IgG4-related inﬂammatory group,
2
although they are distinct different clinical entities. Interest-
ingly, gastric biopsy samples in the IgG4-related group revealed
IgG4-positive lymphoplasmacytic inﬁltrations. A close associa-
tion of histology and serum abnormalities between the IgG4-
related group and the IgG4-related inﬂammatory group suggests
that the pathogenesis of IgG4-positive plasma cell inﬁltrations
into ocular adnexal MZBLs may be induced by conditions
similar to both. Thus, pathogenesis of IgG4-positive plasma cell
inﬁltrations into ocular adnexal MZBLs may be correlated with
a systemic condition that induces unique serum abnormalities.
Ocular adnexal MZBLs with IgG4-positive plasma cells must
be differentiated from ocular adnexal IgG4-related lympho-
plasmacytic disorder. Our biopsy samples showed not only
histological MZBLs but also B cell clonality. These analyses
support the identiﬁcation of our biopsy samples as MZBLs.
Ocular adnexal MZBLs with IgG4-positive plasma cells were
typically associated with elevated levels of IgG4, IgE and sIL-2R,
and polyclonal hypergammaglobulinaemia. One plausible
hypothesis for these serological and immunological abnormali-
ties may be that they are caused by in vivo activation of the
immune system by activated Th2 cells. Activated Th2 cells
produce IgE and induce polyclonal B cell activation,
9 and IgG4 is
induced by a modiﬁed Th2 response.
10 Elevated levels of sIL-2R
reﬂect the in vivo activation of the immune system.
11 Thus, the
cause of the serological abnormalities in the IgG4-related group
may be correlated with activated Th2 cells.
Our study has several limitations. First, each subclass of IgG
was collected retrospectively, and this may have led to some
bias. Second, there were discrepancies in the B cell clonality
between immunohistochemistry and PCR from a gastric sample
of patients 2 and 3. This may have been an incipient clone with
a background of IgG4-positive lymphoplasmacytic inﬁltrations,
although the result of the PCR could also be a false positive.
In conclusion, sclerosing and reactive follicular lesions with
IgG4-positive plasma cells inﬁltrated into ocular adnexal MZBLs
in 9% of cases. Patients having MZBL with IgG4-positive
lymphoplasmacytic inﬁltrations characteristically had elevated
serum levels of IgG4, IgE and sIL-2R, and systemic IgG4-positive
plasma cell inﬁltrations, such as in the recurrent lesion and
stomach. We hypothesise that the pathogenesis of IgG4-positive
plasma cell inﬁltrations into ocular adnexal MZBLs is
correlated with a systemic condition that induces unique serum
abnormalities.
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Take-home messages
< Ocular adnexal marginal zone B cell lymphoma (MZBL)
inﬁltrated by IgG4-positive plasma cells has signiﬁcant
sclerosis in the lesions.
< Patients with MZBL inﬁltrated by IgG4-positive plasma cells
have unique serum abnormalities, that is, elevated levels of
IgG4, IgE and soluble interleukin-2 receptor, and polyclonal
hypergammaglobulinaemia.
< Patients with MZBL inﬁltrated by IgG4-positive plasma cells
also have reactive IgG4-positive lymphoplasmacytic inﬁltra-
tions in the recurrent lesion and in the stomach.
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